← Eichor
Study identifier: NCT06701071 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation

Condition: Infertility, Female  ·  Sponsor: University of Southern California

PhasePhase 4
Planned participants120
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate a long Clomid protocol as compared to a 5-day Clomid protocol for ovarian stimulation in patients with diminished ovarian reserve undergoing ovarian stimulation for in-vitro fertilization. The aim of the long Clomid protocol is to intensify stimulation of the ovaries and reduce both cost and injection burden for patients. Participants will be randomized to receive the long Clomid protocol vs. the typical protocol involving Clomid only for 5 days followed by growth hormone-releasing hormone (GnRH) antagonist. The primary outcome the investigators will evaluate will be the number of mature eggs retrieved.

This description comes directly from the study's public registry record.

Talk to the study team

Richard Paulson  ·  323-409-3026  ·  paulsonivf@havingbabies.com

Rachel Mandelbaum  ·  323-409-3026  ·  mandelbaumivf@havingbabies.com

Always discuss trial participation with your own doctor first.

Locations (1)

HRC FertilityPasadena, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06701071